Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(5): e10580.
Published online 2010 May 11. doi:  10.1371/journal.pone.0010580
PMCID: PMC2867956

Interdomain Interactions Control Ca2+-Dependent Potentiation in the Cation Channel TRPV4

Karl-Wilhelm Koch, Editor


Several Ca2+-permeable channels, including the non-selective cation channel TRPV4, are subject to Ca2+-dependent facilitation. Although it has been clearly demonstrated in functional experiments that calmodulin (CaM) binding to intracellular domains of TRP channels is involved in this process, the molecular mechanism remains elusive. In this study, we provide experimental evidence for a comprehensive molecular model that explains Ca2+-dependent facilitation of TRPV4. In the resting state, an intracellular domain from the channel N terminus forms an autoinhibitory complex with a C-terminal domain that includes a high-affinity CaM binding site. CaM binding, secondary to rises in intracellular Ca2+, displaces the N-terminal domain which may then form a homologous interaction with an identical domain from a second subunit. This represents a novel potentiation mechanism that may also be relevant in other Ca2+-permeable channels.


Ca2+-dependent regulation by calmodulin (CaM) has been demonstrated for a large number of intracellular proteins including Ca2+-permeable plasma membrane cation channels. Often, this provides a negative feedback mechanism that either prevents excessive, potentially deleterious Ca2+ influx into the cell, or defines the time course of channel activity. Indeed, CaM-dependent inhibition is seen in most of the non-selective, Ca2+-permeable cation channels of the TRP group [1], [2], [3], [4], [5]. Within the TRPV subfamily, CaM-dependent regulation has been shown for the capsaicin and temperature-sensitive TRPV1 [3], [6], [7], temperature-sensitive TRPV3 [8], the highly Ca2+-selective epithelial Ca2+ channels TRPV5 and TRPV6 [4], [9], [10], and TRPV4 [11].

TRPV4 is highly expressed in kidney and was originally found to be activated by hypotonic solutions, suggesting a role in renal osmoregulation [12], [13], [14]. Studies thereafter identified multiple other stimuli (phorbol esters, temperature [15], [16], mechanical stimulation [17], [18], [19], [20], [21], [22] and arachidonic acid metabolites [23], [24]) and localizations suggesting diverse modes of activation in sensory and other systems. Like other TRP channels, TRPV4 is subject to dual Ca2+-dependent regulation with channel activity being potentiated and inactivated at Ca2+ concentrations attained during agonist-dependent activation [11], [25]. Ca2+-dependent facilitation has also been described for TRPC5 [26], TRPV3 [8], TRPV6 [9] and TRPA1 [27], [28].

In a previous study, we identified a CaM binding domain in the C terminus of TRPV4 as the structural basis of the Ca2+-dependent potentiation process [11]. Although CaM binding is a prerequisite for potentiation, the molecular mechanism that couples CaM binding to enhanced channel activity has not been resolved. Using protein interaction experiments and functional assays, we show that the molecular correlate of Ca2+-dependent current potentiation is disruption of an interdomain interaction within TRPV4 resulting from CaM binding to a C-terminal site. We provide experimental evidence for an underlying mechanism in which an N-terminal autoinhibitory domain forms a molecular switch that controls facilitation of TRPV4.

Results and Discussion

The C-terminal CaM binding site in TRPV4 binds to the CaM C lobe

Because CaM interaction with a C-terminal binding site in TRPV4 has been shown to be an essential step in the Ca2+-dependent potentiation of TRPV4 [11], we attempted to obtain initial clues about the underlying molecular mechanism by studying the CaM binding geometry. We analyzed the properties of the complex between CaM and C-terminal fragments of the human TRPV4 ortholog, and investigated the structural determinants within the CaM molecule that are involved in binding.

Fluorescence polarization experiments with the carboxyfluorescein-labeled CaM binding peptide, P5, as the tracer molecule (Fig. 1A, Table S1), showed that CaM binding was Ca2+-dependent and half-maximal at 3.2 µM Ca2+ (Fig. 1C). Thus, in contrast to some other TRP channels, where CaM binding is present at nanomolar Ca2+ concentrations [4], [29], CaM binding to TRPV4 depends on Ca2+ concentrations above those in resting cells. The Ca2+ concentration at which CaM binding to P5 was half-maximal is higher than the IC50 for steady-state inhibition of TRPV4 by intracellular Ca2+ in electrophysiological experiments (around 600 nM, [25]). However, during the dynamic response to an agonist, potentiation via this CaM binding site clearly precedes the inactivation process [11]. A possible explanation for the apparent discrepancy in the Ca2+ dependencies is that CaM binding to the full-length channel may occur at lower concentrations than to the short fragment used here. Alternatively, inactivation may be more sensitive to Ca2+, but a slower process than potentiation, or, in the case e.g. of Ca2+ entry through the channel, components of the potentiatory process may be exposed to a higher local Ca2+ concentration than those involved in inactivation.

Figure 1
Lobe-specific CaM binding to TRPV4-C2.

A characteristic feature of the CaM molecule is its symmetry with respect to its domain composition. The homologous N- and C-terminal lobes that both comprise two Ca2+-binding EF hand motifs (Fig. 1B), each expose a hydrophobic interaction domain on the molecular surface secondary to Ca2+ binding and may thus contribute independently to target binding. To quantify the individual affinities of the isolated CaM lobes to P5, we performed P5 fluorescence polarization experiments at different lobe concentrations in 100 µM Ca2+ (Fig. 1D). The Kd values were 400 nM, 700 nM and 25 µM for CaM and the CaM C-terminal (CaM-C) and N-terminal (CaM-N) lobes, respectively, indicating a 36-fold higher affinity of the CaM C lobe over the N lobe. In an independent experimental approach, we subjected a longer C-terminal TRPV4 fragment, C2 (Fig. 1A), to a CaM interaction assay that is based on the AlphaScreen proximity assay technology (Fig. 2, Fig. S1, Methods S1). Using different CaM constructs, we analyzed the relative binding affinities of the two CaM lobes alone or CaM mutants that are Ca2+ binding-deficient in the N-lobe (CaM12), C-lobe (CaM34) or both lobes (CaM1234) at 100 µM Ca2+ (Fig. 1E). Again, the interaction signal was found to be highly dependent on the presence of the functional C-lobe (Fig. 1E). The Ca2+-dependence of the interaction was similar for CaM, CaM12 and CaM34 with EC50 Ca2+ concentrations of 8.8±1.0 µM, 10.7±1.0 µM, 27.0±1.1 µM, respectively (Fig. S2).

Figure 2
AlphaScreen-based CaM interaction assay.

To assess whether this finding is functionally relevant, we tested the effect of overexpression of CaM and CaM mutants on TRPV4 activity. In nominally Ca2+-free solutions, activation of TRPV4 by the phorbol ester 4α-PMA, a partial TRPV4 agonist [30]that we used in a previous study [11], is weak and slow. Addition of Ca2+ after activation by 4α-PMA results in facilitation followed by inactivation of the channel [11]. We measured the current increase on adding Ca2+ (2 mM) in HEK293 cells expressing YFP (not shown) or TRPV4 alone (control), or TRPV4 together with CaM or CaM mutants (Fig. 1F). CaM or the CaM mutants had no effect on spontaneous currents, or currents activated by 4α-PMA in a nominally Ca2+-free solution (not shown). A current increase upon addition of Ca2+ was observed in all cells except those expressing YFP alone. In the latter, currents were not significantly changed at +100 mV (difference: 0.133±0.438 pA/pF, n = 8, p = 0.7688), but significantly decreased at -100 mV (difference-1.097±0.436 pA/pF, n = 8, p = 0.04), probably due to a decrease in leakage current. CaM slightly increased the TRPV4 response to Ca2+, but the increase is not statistically significant, indicating that in HEK cells, the CaM concentration is not a limiting factor in TRPV4 potentiation. CaM mutants with a dysfunctional C lobe (CaM34, CaM1234) had no effect (Fig. 1F), probably because these mutants do not interact with the TRPV4 C-terminal domain and do not functionally compete with endogenous CaM. In contrast, current increases were significantly smaller with the mutant CaM12 that binds to TRPV4. This mutant may bind and displace endogenous CaM, but, owing to the N-terminal mutation, cannot fully substitute for the wild type molecule. This suggests that, in spite of its lower affinity to the C-terminal CaM binding site in TRPV4, the CaM N lobe contributes functionally to TRPV4 potentiation by a mechanism which remains unclear.

These results with CaM mutants differ from those on Ca2+-dependent potentiation in other TRP channels. Coexpression of CaM1234 abolished TRPC6 activation secondary to Gq protein-coupled receptor activation or diacylglycerol application [31], [32] and strongly decreased activation of the adenosine diphosphoribose-sensitive channel TRPM2 [33], [34]. For TRPM2, co-immunoprecipitation experiments demonstrated CaM1234 binding to the channel, indicating that Ca2+-independent CaM binding contributes to the facilitation mechanism. In contrast to these findings, TRPV4 neither binds to CaM in Ca2+-free buffers, nor to CaM1234, and potentiation of its activity directly depends on CaM interaction triggered by a rise in Ca2+.

How does CaM binding facilitate Ca2+ entry through TRPV4 at the molecular level? Two general molecular switching mechanisms seemed conceivable. The first comprises a ternary interaction in which Ca2+-loaded CaM binds to two different sites within the TRPV4 protein thus bringing two regulatory domains in proximity to each other. Indeed, asymmetrical CaM binding has been demonstrated for the pore-forming subunits of the CaV1/CaV2 [35], [36] and SK [37], [38] channel families, and a similar mechanism has been proposed for the Ca2+-dependent desensitization of TRPV1 [6], [7]. Using CaM overlay experiments on a peptide library representing the cytosolic termini of TRPV4 and fluorescence polarization experiments we identified three additional CaM binding sites in TRPV4 that may serve as anchoring domains for the CaM N lobe (Fig. S3). However, in fluorescence polarization experiments, their CaM affinities were in the micromolar range (Fig. S4) and none bound to CaM-N with higher affinity than to CaM-C (Table S2).

CaM binding disrupts an interdomain interaction

The alternative scenario for CaM-dependent current facilitation in TRPV4 involves a disinhibition process in which CaM binding displaces a regulatory domain that is attached to TRPV4 in the resting state. Prototypical mechanisms involving the displacement of autoinhibitory domains from a functional center are found in the CaM-dependent activation of CaMK II [39] and the plasma membrane Ca2+ pump [40], [41]. Multiple lines of evidence indicate that this is indeed the mechanism of the CaM-dependent potentiation in TRPV4.

First, we did a complementation experiment to test whether a CaM molecule that binds to the C2 fragment of TRPV4 through its C-lobe can form an additional interaction with another CaM binding domain thus forming a ternary complex. We focused on the N-terminal P2 peptide which with its accumulation of positively charged amino acids around a central tryptophan residue resembles the CaM-binding M13 peptide from the skeletal muscle myosin light chain kinase, a prototypical CaM binding motif. We used an AlphaScreen-based proximity assay (Fig. 2, Methods S1) in which the acceptor beads were coated with the C-terminal fragment C2-Flag, and the donor beads either with the N-terminal CaM binding peptide P2-biotin, or, as a negative control, with C2-biotin. The interaction between the proteins was measured in the presence of increasing CaM concentrations in 100 µM Ca2+ or 1 mM EGTA (Fig. 3A). Surprisingly, instead of CaM-dependent complex formation, a strong constitutive interaction between the N- and C-terminal TRPV4 fragments was observed in the absence of CaM (Fig. 3A). CaM competitively reduced this interaction in a Ca2+-dependent fashion with an IC50 of 166 nM in 100 µM Ca2+, a value that is in agreement with the Kd observed for its binding to C2 (see Fig. 1D). The control reaction in which both acceptor and donor beads were coated with the C2 protein did not show interaction in the absence or presence of CaM (Fig. 3A).

Figure 3
The C2 fragment interacts with an N-terminal domain.

To determine the Ca2+-dependence of the complex between P2 and C2, an AlphaScreen experiment was performed in the absence of CaM but with Ca2+ concentrations between 10 nM and 10 mM (Fig. 3B). The interaction was already present at 0 Ca2+ and essentially Ca2+-insensitive over a wide range of Ca2+ concentrations. Very high Ca2+ concentrations above 100 µM, however, inhibited binding of the fragments, a process that is probably secondary to unspecific Ca2+ binding and has been observed for other protein interactions including CaM binding to TRPV4 [11].

To more finely map the interaction site, we then performed overlay experiments with a partial peptide library from the TRPV4 N terminus (Fig. S3A). Probing with the C2 fragment resulted in strong binding to a site that overlaps with the P2 peptide. In a similar fashion, a peptide array from the TRPV4 C terminus was probed with the N-terminal N3 fragment (Fig. 1A) that includes P2 (Fig. S3B). Consistent with the finding that CaM inhibits the interaction, strong interaction was found with a region that corresponds to the CaM binding peptide P5.

The interdomain interaction could also be shown using the longer N-terminal TRPV4 fragments N2 (wt in Fig. 3C) and N3 (data not shown) instead of P2. In an AlphaScreen interaction experiment, donor and acceptor beads were incubated with 10 nM C2-biotin and N2-Flag at concentrations ranging from 30 pM to 1.5 µM, respectively (Fig. 3C). Increasing N2-Flag concentrations resulted in increasing C2 interaction signals with a maximum at the bead capacity of approximately 10 nM bound protein. Further increases in the N2-Flag concentration led to signal reduction owing to a hook effect of the assay system, demonstrating specific interaction of the fragments (see Methods S1).

Secondly, N2 mutants in which key basic amino acids within the N-terminal binding motif were changed into alanine showed significantly weaker binding to C2. We used site-directed mutagenesis to create N2 mutants that lack either the hydrophobic (WIA) or the positively charged residues (KRA) in the N-terminal interaction domain (Fig. 3D). In AlphaScreen-based C2 interaction assays, both constructs, WIA and KRA, had a significantly lower binding affinity to the C2 fragment (Fig. 3C,E) with respective AlphaScreen signals of 48.4±5.5% and 14.8±2.1% of the wild type at the given component concentrations.

The same was found when CFP- and YFP- fusion protein of the full-length N and C-termini, respectively, (N1, C1, Fig. 1A) were tested for interaction in fluorescence resonance energy transfer (FRET) experiments after coexpression in HEK293 cells (Fig. 4). This is in agreement with a recent study [42] that showed high FRET efficiency in TRPV4 for both homologous N-terminal and N-terminal to C-terminal interactions. Interestingly, the interaction site represented by the P2 peptide is close to a proline-rich domain that has been shown to interact with PACSIN 3, a regulatory protein that controls basal TRPV4 activity and stimulus specificity [43], [44].

Figure 4
The TRPV4 N and C termini interact in HEK293 cells.

To investigate the interaction in the full-length channel protein, we used a TRPV4 expression construct in which CFP and YFP were fused to the N- and C termini, respectively (Fig. 5). Fluorescence resonance energy transfer (FRET) experiments in unstimulated HEK293 cells expressing the construct revealed a significantly stronger FRET efficiency between the fluorophores than in cells cotransfected with a TRPV4-CFP fusion construct and YFP (Fig. 5A,B). The same was found in cells cotransfected with CFP-TRPV4 and TRPV4-YFP (Fig. 5B) suggesting that interactions can occur between subunits in the homotetrameric channel. All constructs resulted in functional channels (data not shown). Interestingly, both stimulation of CFP-TRPV4-YFP by decreases in the extracellular osmolarity (Fig. 5C) or application of 4α-PMA (not shown) in Ca2+-containing buffer, and intracellular Ca2+ release after stimulation of the endogenous M3 muscarinic receptor resulted in transient decreases in the FRET- and concomitant increases in the donor channel fluorescences, indicating a decrease in FRET efficiency (Fig. 5C).

Figure 5
Calcium-dependent interdomain interaction in TRPV4.

Inhibition of the interaction between N and C termini renders TRPV4 permanently potentiated

As a third line of evidence, the full-length WIA and KRA mutants displayed significantly enhanced currents during activation in nominally Ca2+-free media (Fig. 6). In whole-cell patch-clamp experiments, TRPV4 wild type showed an initial decrease in spontaneous activity after establishment of the whole cell configuration (Fig. 6A). Addition of 4α-PMA thereafter in the nominal absence of Ca2+ led to a slow, small increase in currents which after reaching a plateau were then strongly, but transiently potentiated on readdition of Ca2+. Potentiation was rapidly followed by Ca2+-dependent inhibition. Both mutants showed clear differences to wild type TRPV4. Significantly larger currents were activated by 4α-PMA in the nominally Ca2+-free medium and no potentiation, only inhibition was observed on readdition of Ca2+ (Fig. 6B, C). Interestingly, the current densities attained by the mutants in 4α-PMA were similar to those for wild type TRPV4 after potentiation by Ca2+. Thus, channels with the mutations that prevent or reduce interactions between the N and C termini do not require increases in intracellular Ca2+ for strong current activation.

Figure 6
TRPV4 mutations that disrupt the interaction between the N- and C-terminal domains result in channels that are strongly activated in the absence of extracellular Ca2+.

All data provide strong evidence for an interaction in TRPV4 between an N-terminal domain represented by the P2 peptide and a site in the C terminus, P5, that also binds to CaM. Our functional data show that disruption of the interaction by mutagenesis of key amino acids leads to constitutive current potentiation when the channel is stimulated in the absence of extracellular Ca2+. This is in good agreement with a previous study [11] that demonstrated that TRPV4 mutants in which CaM binding to the C terminus is abolished result in channels not potentiated by Ca2+ addition.

A similar interdomain interaction mechanism has also been found in cyclic nucleotide-gated channels [45]. Here, an N-terminal domain is capable of interacting with both the cyclic nucleotide binding region in the C terminus of the protein and Ca2+/CaM. In contrast to TRPV4, however, this is functionally coupled to autoregulatory channel inactivation. The same group demonstrated using GFP-FRET experiments that the interaction occurs between adjacent subunits of the tetrameric protein rather than within the same subunit [46].

The N-terminal interaction domain is capable of dimerization

When the chromatographically purified N2 protein was subjected to SDS-PAGE, a strong band of the expected size of 34.8 kD was detected (Fig. 7A). In addition, a second band was visible with a molecular weight compatible with a dimeric form of N2 (Fig. 7A). In gel filtration experiments under non-denaturing conditions, a single peak was detected at a size that corresponds to the dimeric form (Fig. S5). We then used an AlphaScreen-based assay to investigate the interaction of the N-terminal P2 peptide with the wild type N2 fragment or the N2 mutants WIA and KRA in nominally Ca2+-free buffers (Fig. 7B). P2 bound strongly to wild type N2 and the WIA mutant, but not to the KRA mutant. Similar results were obtained using the biotinylated N2 fragment instead of the P2 peptide (data not shown). These data show that the N-terminal domain constituted by the P2 peptide, in addition to its affinity for the C-terminal binding site, has the ability to form homodimeric interactions.

Figure 7
The P2 peptide contributes to homodimerization of the TRPV4 N terminus.

FRET experiments were performed to validate the interaction under intracellular conditions (Fig. 7C). N1-YFP was coexpressed with N1-CFP or CFP alone in HEK293 cells and the donor fluorescence measured during selective YFP photobleaching. The respective maximal relative donor fluorescence increases after acceptor bleaching were 1.27±0.03 and 1.04±0.01. We conclude that there is significant interaction between two molecules of the full-length TRPV4 N terminus that is dependent on the integrity of the domain formed by the P2 peptide.

It is known that TRPV4 forms homotetrameric complexes [47]. The N termini of adjacent subunits are thus readily accessible for homologous interaction. Indeed, previous studies [42] demonstrated that strong binding between the N-terminal tails exists in TRPV4. Studies in TRPV4 [48], TRPV5 [49] and TRPV6 [50] indicated that specific N-terminal ankyrin domains are crucial structures for channel self assembly. However, the N2 fragment that includes the P2 peptide is located N-terminal to the ankyrin domains (Fig. 1A). The dual affinity of this domain to both a homologous domain of a second subunit and the C-terminal CaM binding site suggests that it may contribute to transient rather than static interactions in the functional channel.

Dual role of the N-terminal interaction domain

To investigate which of the alternative interactions of the P2 peptide is relevant in the absence and presence of CaM binding to the TRPV4 C terminus, we performed a series of competition experiments (Fig. 7D,E). AlphaScreen acceptor and donor beads were coated with C2-Flag and either P2-biotin (Fig. 7D) or CaM-biotin at 100 µM Ca2+ (Fig. 7E) and incubated with untagged C2 or N2 competitor proteins at the indicated concentrations. In the P2/C2 complex (Fig. 7D), the IC50 values for C2 and N2 were 47 nM and 166 nM, respectively, indicating a 3.5-fold higher apparent affinity of the C2 fragment. A similar finding was observed when the CaM/C2 interaction was subjected to competition by C2 or N2 (Fig. 7E). The IC50 values for C2 and N2 were 38 nM and 522 nM. Taken together, the data indicate a higher affinity of the N-terminal binding site towards C2 than to a second N-terminal fragment, suggesting that in the resting state of the channel when CaM is not bound to the C-terminal binding site, the interaction between the N and C termini prevails.

In summary, this study provides a comprehensive model for the Ca2+-dependent potentiation of TRPV4 currents. Using different experimental strategies, we have demonstrated that an interaction between an N-terminal and a C-terminal site in TRPV4 is present at nanomolar Ca2+ concentrations (Fig. 8A), but becomes disrupted secondary to CaM binding to the TRPV4 C terminus at micromolar Ca2+ concentrations (Fig. 8B). In in vitro FRET experiments, the interaction was shown to occur between channel subunits, presumably in the channel homotetramer. However, from the experimental data, we cannot exclude the possibility that the N and C termini of a single channel subunit can interact.

Figure 8
Proposed TRPV4 potentiation mechanism.

Evidence for an interaction between N and C termini was also obtained in functional experiments. While TRPV4 mutants that are CaM binding-deficient result in currents that are small and do not potentiate secondary to rises in the intracellular Ca2+ concentration [11], mutants in which the interaction is absent result in large currents in the absence of Ca2+ (Fig. 6). A second, homologous interaction between the N termini of adjacent TRPV4 subunits that is present when CaM is bound to the C-terminal site may contribute to conformational changes that lead to current facilitation (Fig. 8B), but we currently have no functional evidence in support of this. This model represents a new Ca2+-dependent regulatory mechanism that may also be found in other CaM-regulated cation channels.

Materials and Methods

AlphaScreen protein interaction measurements

Proteins were expressed in E. coli, affinity purified and biotinylated if applicable (for details see Methods S1). For protein interaction measurements, a proximity assay system based on the AlphaScreen technology (PerkinElmer) was used (see Methods S1). Briefly, streptavidin-coated AlphaScreen donor and anti-Flag acceptor beads at a final concentration of 16.7 µg/ml were incubated in a 384-well plate format (OptiPlate-384, PerkinElmer) with C2-GST-biotin or P2-biotin and the respective Flag-tagged interaction protein at concentrations of 10 nM, if not otherwise indicated. Assay buffer conditions were 50 mM Tris, pH 7.4, 100 mM KCl, and 0.1% BSA. After incubation for 90 min at room temperature, the AlphaScreen output signal was recorded in a Fusion alpha FP instrument (PerkinElmer) at 2 s reading time per well. AlphaScreen signals are given as mean±SEM in counts per second (cps) units.

Fluorescence polarization

Tracer peptides were synthesized and coupled to carboxyfluorescein (Dr. Sven Rothemund, Core unit peptide technologies, IZKF, Leipzig). Protein interaction experiments were performed in buffers containing 50 mM Tris, pH 7.5, 100 mM KCl, 0.1% BSA and calcium at the indicated concentrations. Calcium concentrations below 50 µM were buffered with HEDTA, EGTA or EDTA at a buffer concentration of 10 mM. CaM concentrations were 10 µM or as indicated; the tracer peptide concentration was 100 nM. Fluorescence anisotropy was measured in a 384-well black multititer plate (Fluotrac 200, Greiner) using a Fusion alpha FP instrument (PerkinElmer) at 1 s reading time per well. Fluorescence polarization (FP) was calculated according to:

equation image

with Ipar and Iperp as the fluorescence emission intensities in planes parallel and perpendicular to the excitation plane. FP signals are given as mean±SEM of triplicate measurements in milli-P (mP) units.

GFP-FRET in vivo interaction

Single-cell GFP-FRET was measured in a fluorescence imaging system. Excitation of donor (CFP) and acceptor (YFP) fluorescence was at 430 nm and 520 nm, respectively. After baseline recording, the acceptor fluorescence was selectively photobleached by 30 cycles of 5 s expositions at 520 nm while measuring the donor and acceptor fluorescences. Both channels were normalized to the emission intensity immediately before acceptor bleaching. (See Methods S1 for details).


Patch clamp recordings were performed on HEK293 cells in the whole cell configuration. Cells were clamped at a potential of −20 mV, and current-voltage (I–V) relations were obtained from voltage ramps from −100 mV to +100 mV. The standard extracellular solution contained 140 mM NaCl, 5 mM CsCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES (pH 7.4 with NaOH). In nominally Ca2+-free solutions, Ca2+ was omitted. The standard intracellular solution contained 110 mM cesium methanesulfonate, 25 mM CsCl, 2 mM MgCl2, 0.362 mM CaCl2, 1 mM EGTA, and 30 mM HEPES (pH 7.2 with CsOH) with a calculated [Ca2+] of 100 nM. (See Methods S1 for details).

Supporting Information

Methods S1

Supplementary Methods.

(0.04 MB DOC)

Figure S1

AlphaScreen-based CaM interaction assay. Streptavidin-coated AlphaScreen donor- and anti-Flag-coated acceptor beads were incubated with the indicated concentrations of CaM-biotin and 6 nM C2-Flag (A) or C2-Flag and 10 nM CaM-biotin (B). Data points show mean±SEM of measurements in buffer containing 100 µM Ca2+ (filled squares) or 1 mM EGTA (open squares). The AlphaScreen output signal is shown in arbitrary units (kilo counts per second, kcps).

(0.07 MB TIF)

Figure S2

Ca2+-dependent binding of C2 to CaM or CaM mutants that are partially Ca2+-binding defective. The Ca2+-dependence of C2-biotin binding to wild type CaM-Flag or mutants that are Ca2+-binding deficient in the N lobe (CaM12), the C lobe (CaM34) or both lobes (CaM1234) was measured in an AlphaScreen assay at the indicated Ca2+ concentrations. Half maximal binding was observed at 8.8±1.0 µM, 10.7±1.0 µM, 27.0±1.1 µM Ca2+ for CaM, CaM12 and CaM34, respectively with a common hill coefficient of 2.0 (n = 3 independent experiments in triplicate). CaM1234 did not show measurable C2 interaction. To demonstrate the Ca2+-independence of the assay system itself, a GST-Flag-biotin fusion protein was incubated with the AlphaScreen beads at 100 µM Ca2+ or 1 mM EGTA (inset). The AlphaScreen readout was independent of the Ca2+ concentration.

(0.07 MB TIF)

Figure S3

Identification of CaM binding and interdomain interaction sites in TRPV4. (A) A library of 20-mer peptides overlapping by 18 amino acids and covering the TRPV4 N terminus was spotted on filter paper and probed with biotinylated CaM or C2 at 100 µM Ca2+. The peptide dots are shown at the start of the respective 20-mer peptide within the TRPV4 sequence graph. Thus, the underlying peptide sequence actually extends 20 amino acids, corresponding to 10 dots, to the right. The positions of the ankyrin domains, the fragments N2 and N3 and peptides P1, P2 and P3 are indicated. (B) Peptide library of the TRPV4 C terminus, probed with biotinylated CaM or N2 fragment. The positions of the C2-fragment and peptides P4 and P5 are indicated.

(0.31 MBTIF)

Figure S4

CaM binding in the CaM interaction sites in TRPV4. (A–E), In fluorescence polarization experiments, the carboxyfluorescein-labeled peptides P1 (A), P2 (B), P3 (C), P4 (D) and P5 (E) were incubated with CaM, CaM mutants or isolated CaM lobes (see Fig. 1B in main text) at concentrations between 0.1 nM and 10 µM. The respective EC50 values are given in Table S2.

(0.11 MB TIF)

Figure S5

The N2 fragment forms dimers in gel filtration experiments. (A) N2 results in a monophasic elution profile with an apparent molecular size that corresponds with a dimeric form of the protein. (B) Calibration was done with a commercial protein mixture with the indicated molecular weights.

(0.07 MB TIF)

Table S1

Positions of the TRPV4 fragments used in the study.

(0.03 MB DOC)

Table S2

CaM binding properties of the putative CaM interaction peptides.

(0.03 MB DOC)


We would like to thank Sven Rothemund for peptide syntheses, Jürgen Kirchberger for helping with protein purification and Stine Beyer for excellent assistance. Nadine Müller helped with some of the patch clamp experiments and Eva Braun provided excellent technical assistance.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by the IZKF Leipzig, the Deutsche Forschungsgemeinschaft and Bundesministerium für Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Zhang Z, Tang J, Tikunova S, Johnson JD, Chen Z, et al. Activation of Trp3 by inositol 1,4,5-trisphosphate receptors through displacement of inhibitory calmodulin from a common binding domain. Proc Natl Acad Sci U S A. 2001;98:3168–3173. [PubMed]
2. Singh BB, Liu X, Tang J, Zhu MX, Ambudkar IS. Calmodulin regulates Ca(2+)-dependent feedback inhibition of store-operated Ca(2+) influx by interaction with a site in the C terminus of TrpC1. Mol Cell. 2002;9:739–750. [PubMed]
3. Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H, et al. Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc Natl Acad Sci U S A. 2003;100:8002–8006. [PubMed]
4. Niemeyer BA, Bergs C, Wissenbach U, Flockerzi V, Trost C. Competitive regulation of CaT-like-mediated Ca2+ entry by protein kinase C and calmodulin. Proc Natl Acad Sci U S A. 2001;98:3600–3605. [PubMed]
5. Tang J, Lin Y, Zhang Z, Tikunova S, Birnbaumer L, et al. Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels. J Biol Chem. 2001;276:21303–21310. [PMC free article] [PubMed]
6. Rosenbaum T, Gordon-Shaag A, Munari M, Gordon SE. Ca2+/calmodulin modulates TRPV1 activation by capsaicin. J Gen Physiol. 2004;123:53–62. [PMC free article] [PubMed]
7. Lishko PV, Procko E, Jin X, Phelps CB, Gaudet R. The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. Neuron. 2007;54:905–918. [PubMed]
8. Xiao R, Tang J, Wang C, Colton CK, Tian J, et al. Calcium plays a central role in the sensitization of TRPV3 channel to repetitive stimulations. J Biol Chem. 2008;283:6162–6174. [PMC free article] [PubMed]
9. Lambers TT, Weidema AF, Nilius B, Hoenderop JG, Bindels RJ. Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin. J Biol Chem. 2004;279:28855–28861. [PubMed]
10. Bodding M, Flockerzi V. Ca2+ dependence of the Ca2+-selective TRPV6 channel. J Biol Chem. 2004;279:36546–36552. [PubMed]
11. Strotmann R, Schultz G, Plant TD. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site. J Biol Chem. 2003;278:26541–26549. [PubMed]
12. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000;2:695–702. [PubMed]
13. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell. 2000;103:525–535. [PMC free article] [PubMed]
14. Wissenbach U, Bodding M, Freichel M, Flockerzi V. Trp12, a novel Trp related protein from kidney. FEBS Lett. 2000;485:127–134. [PubMed]
15. Guler AD, Lee H, Iida T, Shimizu I, Tominaga M, et al. Heat-evoked activation of the ion channel, TRPV4. J Neurosci. 2002;22:6408–6414. [PubMed]
16. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, et al. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem. 2002;277:47044–47051. [PubMed]
17. Gao X, Wu L, O'Neil RG. Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways. J Biol Chem. 2003;278:27129–27137. [PubMed]
18. Wu L, Gao X, Brown RC, Heller S, O'Neil RG. Dual role of the TRPV4 channel as a sensor of flow and osmolality in renal epithelial cells. Am J Physiol Renal Physiol. 2007;293:F1699–1713. [PubMed]
19. Andrade YN, Fernandes J, Vazquez E, Fernandez-Fernandez JM, Arniges M, et al. TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity. J Cell Biol. 2005;168:869–874. [PMC free article] [PubMed]
20. Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2003;100(Suppl 2):14531–14536. [PubMed]
21. Lorenzo IM, Liedtke W, Sanderson MJ, Valverde MA. TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells. Proc Natl Acad Sci U S A. 2008;105:12611–12616. [PubMed]
22. Hartmannsgruber V, Heyken WT, Kacik M, Kaistha A, Grgic I, et al. Arterial response to shear stress critically depends on endothelial TRPV4 expression. PLoS One. 2007;2:e827. [PMC free article] [PubMed]
23. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434–438. [PubMed]
24. Vriens J, Owsianik G, Fisslthaler B, Suzuki M, Janssens A, et al. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res. 2005;97:908–915. [PubMed]
25. Watanabe H, Vriens J, Janssens A, Wondergem R, Droogmans G, et al. Modulation of TRPV4 gating by intra- and extracellular Ca2+. Cell Calcium. 2003;33:489–495. [PubMed]
26. Ordaz B, Tang J, Xiao R, Salgado A, Sampieri A, et al. Calmodulin and calcium interplay in the modulation of TRPC5 channel activity. Identification of a novel C-terminal domain for calcium/calmodulin-mediated facilitation. J Biol Chem. 2005;280:30788–30796. [PubMed]
27. Doerner JF, Gisselmann G, Hatt H, Wetzel CH. Transient receptor potential channel A1 is directly gated by calcium ions. J Biol Chem. 2007;282:13180–13189. [PubMed]
28. Zurborg S, Yurgionas B, Jira JA, Caspani O, Heppenstall PA. Direct activation of the ion channel TRPA1 by Ca2+. Nat Neurosci. 2007;10:277–279. [PubMed]
29. Hirnet D, Olausson J, Fecher-Trost C, Bodding M, Nastainczyk W, et al. The TRPV6 gene, cDNA and protein. Cell Calcium. 2003;33:509–518. [PubMed]
30. Vriens J, Owsianik G, Janssens A, Voets T, Nilius B. Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4. J Biol Chem. 2007;282:12796–12803. [PubMed]
31. Boulay G. Ca(2+)-calmodulin regulates receptor-operated Ca(2+) entry activity of TRPC6 in HEK-293 cells. Cell Calcium. 2002;32:201–207. [PubMed]
32. Shi J, Mori E, Mori Y, Mori M, Li J, et al. Multiple regulation by calcium of murine homologues of transient receptor potential proteins TRPC6 and TRPC7 expressed in HEK293 cells. J Physiol. 2004;561:415–432. [PubMed]
33. McHugh D, Flemming R, Xu SZ, Perraud AL, Beech DJ. Critical intracellular Ca2+ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation. J Biol Chem. 2003;278:11002–11006. [PubMed]
34. Tong Q, Zhang W, Conrad K, Mostoller K, Cheung JY, et al. Regulation of the transient receptor potential channel TRPM2 by the Ca2+ sensor calmodulin. J Biol Chem. 2006;281:9076–9085. [PubMed]
35. Pitt GS, Zuhlke RD, Hudmon A, Schulman H, Reuter H, et al. Molecular basis of calmodulin tethering and Ca2+-dependent inactivation of L-type Ca2+ channels. J Biol Chem. 2001;276:30794–30802. [PubMed]
36. Liang H, DeMaria CD, Erickson MG, Mori MX, Alseikhan BA, et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron. 2003;39:951–960. [PubMed]
37. Schumacher MA, Rivard AF, Bachinger HP, Adelman JP. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature. 2001;410:1120–1124. [PubMed]
38. Bruening-Wright A, Schumacher MA, Adelman JP, Maylie J. Localization of the activation gate for small conductance Ca2+-activated K+ channels. J Neurosci. 2002;22:6499–6506. [PubMed]
39. Payne ME, Fong YL, Ono T, Colbran RJ, Kemp BE, et al. Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem. 1988;263:7190–7195. [PubMed]
40. Enyedi A, Vorherr T, James P, McCormick DJ, Filoteo AG, et al. The calmodulin binding domain of the plasma membrane Ca2+ pump interacts both with calmodulin and with another part of the pump. J Biol Chem. 1989;264:12313–12321. [PubMed]
41. Paszty K, Penheiter AR, Verma AK, Padanyi R, Filoteo AG, et al. Asp1080 upstream of the calmodulin-binding domain is critical for autoinhibition of hPMCA4b. J Biol Chem. 2002;277:36146–36151. [PubMed]
42. Hellwig N, Albrecht N, Harteneck C, Schultz G, Schaefer M. Homo- and heteromeric assembly of TRPV channel subunits. J Cell Sci. 2005;118:917–928. [PubMed]
43. D'Hoedt D, Owsianik G, Prenen J, Cuajungco MP, Grimm C, et al. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem. 2008;283:6272–6280. [PubMed]
44. Cuajungco MP, Grimm C, Oshima K, D'Hoedt D, Nilius B, et al. PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4. J Biol Chem. 2006;281:18753–18762. [PubMed]
45. Varnum MD, Zagotta WN. Interdomain interactions underlying activation of cyclic nucleotide-gated channels. Science. 1997;278:110–113. [PubMed]
46. Zheng J, Varnum MD, Zagotta WN. Disruption of an intersubunit interaction underlies Ca2+-calmodulin modulation of cyclic nucleotide-gated channels. J Neurosci. 2003;23:8167–8175. [PubMed]
47. Schaefer M. Homo- and heteromeric assembly of TRP channel subunits. Pflugers Arch. 2005;451:35–42. [PubMed]
48. Arniges M, Fernandez-Fernandez JM, Albrecht N, Schaefer M, Valverde MA. J Biol Chem; 2005. Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking. [PubMed]
49. Chang Q, Gyftogianni E, van de Graaf SF, Hoefs S, Weidema FA, et al. Molecular determinants in TRPV5 channel assembly. J Biol Chem. 2004;279:54304–54311. [PubMed]
50. Erler I, Hirnet D, Wissenbach U, Flockerzi V, Niemeyer BA. Ca2+-selective transient receptor potential V channel architecture and function require a specific ankyrin repeat. J Biol Chem. 2004;279:34456–34463. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science